Serial Number 98123490
Registration 7709746
700

Registration Progress

Application Filed
Aug 9, 2023
Under Examination
Approved for Publication
Jan 14, 2025
Published for Opposition
Jan 14, 2025
Registered
Mar 4, 2025

Trademark Image

Basic Information

Serial Number
98123490
Registration Number
7709746
Filing Date
August 9, 2023
Registration Date
March 4, 2025
Published for Opposition
January 14, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 4, 2025
Registration
Registered
Classes
005

Rights Holder

REGENXBIO Inc.

03
Address
9804 Medical Center Drive
Rockville, MD 20850

Ownership History

REGENXBIO Inc.

Original Applicant
03
Rockville, MD

REGENXBIO Inc.

Owner at Publication
03
Rockville, MD

REGENXBIO Inc.

Original Registrant
03
Rockville, MD

Legal Representation

Attorney
William R. Samuels

USPTO Deadlines

Next Deadline
2053 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-04)
Due Date
March 04, 2031
Grace Period Ends
September 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
Mar 4, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 4, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 14, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 14, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 8, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 12, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 12, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 12, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 23, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 22, 2024 ALIE A ASSIGNED TO LIE Loading...
Oct 22, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 22, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 12, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 17, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 17, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 17, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 10, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 8, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 7, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 12, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy
First Use Anywhere: Sep 1, 2014
First Use in Commerce: Sep 1, 2014

Additional Information

Design Mark
The mark consists of a cluster of circles of varying size which create a larger circle. The cluster of circles surround a circle with a triangular shape inside.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005